Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Kaylee Nichols, PharmD Candidate 2022
Advertisement
Articles by Kaylee Nichols, PharmD Candidate 2022
Advertisement
Latest Updated Articles
Overview of Nurtec ODT for Prevention of Episodic MigrainePublished: January 4th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
3
FDA Approves Poherdy, First Biosimilar to Perjeta, For HER2 Breast Cancer Indications
4
When to Call, When to Counsel: Statin Drug Interactions
5
